title: Attempted prophylaxis of human immunodeficiency virus type 1 infection in chimpanzees with a nonnucleoside reverse transcriptase inhibitor.
authors.affiliation: Merck Research Laboratories, West Point, Pennsylvania 19486.
authors.forename: W A
authors.initials: WA
authors.lastname: Schleif
authors.forename: K K
authors.initials: KK
authors.lastname: Murthy
authors.forename: V V
authors.initials: VV
authors.lastname: Sardana
authors.forename: C L
authors.initials: CL
authors.lastname: Schneider
authors.forename: V W
authors.initials: VW
authors.lastname: Byrnes
authors.forename: K E
authors.initials: KE
authors.lastname: Cobb
authors.forename: E
authors.initials: E
authors.lastname: Roth
authors.forename: J A
authors.initials: JA
authors.lastname: Wolfgang
authors.forename: J M
authors.initials: JM
authors.lastname: Hoffman
authors.forename: A M
authors.initials: AM
authors.lastname: Smith
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D001583:Benzoxazoles / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical; D015658:HIV Infections / Q000517:prevention & control*; D054303:HIV Reverse Transcriptase; D002679:Pan troglodytes; D011728:Pyridones / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors
chemical_list: D000998:Antiviral Agents; D001583:Benzoxazoles; D011728:Pyridones; D018894:Reverse Transcriptase Inhibitors; C076250:L 696229; D054303:HIV Reverse Transcriptase